Works by Nasroulah, Federico

Results: 4
    1

    Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 16, doi. 10.1093/jjco/hyac155
    By:
    • Tomita, Yoshihiko;
    • Kobayashi, Ko;
    • Kimura, Go;
    • Oya, Mototsugu;
    • Uemura, Hirotsugu;
    • Nishiyama, Hiroyuki;
    • Galsky, Matthew D;
    • Nasroulah, Federico;
    • Collette, Sandra;
    • Broughton, Edward;
    • Ünsal-Kaçmaz, Keziban;
    • Kamisuki, Yukinori;
    • Bajorin, Dean F
    Publication type:
    Article
    2

    Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.

    Published in:
    2017
    By:
    • Cohn, Allen;
    • Yoshino, Takayuki;
    • Heinemann, Volker;
    • Obermannova, Radka;
    • Bodoky, György;
    • Prausová, Jana;
    • Garcia-Carbonero, Rocio;
    • Ciuleanu, Tudor;
    • Garcia-Alfonso, Pilar;
    • Portnoy, David;
    • Van Cutsem, Eric;
    • Yamazaki, Kentaro;
    • Clingan, Philip;
    • Polikoff, Jonathon;
    • Lonardi, Sara;
    • O'Brien, Lisa;
    • Gao, Ling;
    • Yang, Ling;
    • Ferry, David;
    • Nasroulah, Federico
    Publication type:
    journal article
    3
    4